\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationAntwerpen
ProgrammesThis two-day event will provide an overview of lessons learnt from the COVID pandemic and provide you with options to be globally prepared for future health threats in a forwardlooking scene. The role of the European partnerships in pandemic preparedness will be discussed. Experts from across the globe will also give insightful keynotes and presentations on the topic of pandemic preparedness.
This Belgian presidency conference is coordinated by the Department for Economy, Science and Innovation of the Flemish government, in collaboration with the Research Department of the Public Service of Wallonia, the Department for Care of the Flemish government and the Federal Public Service on Public Health, and is co-financed by the European Commission.
Initially, the event was communicated as on invitation only. As there are a few places left, it is opened to a broader range of stakeholders. You can register for the event here. Deadline to register is 30 April end of the day.
More information and the detailed programme is available on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
